Hearings begin to finalize Purdue Pharma $7.4 billion bankruptcy settlement plan
Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer ...
Latest opioid settlement plan with OxyContin maker Purdue and Sackler family getting few objections
If U.S. Bankruptcy Judge Sean Lane abides, it will close a long chapter — and maybe the entire book — on a legal odyssey over ...
The Daily Courier
Opioid settlement with OxyContin maker Purdue and Sackler family could end years of legal battles
Lawyers representing OxyContin maker Purdue Pharma, cities, states, counties, Native American tribes, people with addiction ...
Purdue Pharma urges bankruptcy judge to approve $7.4 billion opioid settlement
OxyContin maker Purdue Pharma urged a bankruptcy judge on Wednesday to approve a restructuring plan that includes a $7.4 ...
Reuters
Purdue Pharma gets over 99% voting support for bankruptcy plan
NEW YORK, Oct 21 (Reuters) - More than 99% of bankrupt drugmaker Purdue Pharma's creditors voted to accept a $7.4 billion settlement of legal claims related to the company's sales of addictive opioid ...
Hosted on MSN
Purdue Creditors Vote for $7.4 Billion Plan to End Bankruptcy
(Bloomberg) -- Creditors of Purdue Pharma voted in favor of the opioid maker’s proposal to exit bankruptcy and pay billions to communities and individuals who say they were harmed by the company’s ...
WTNH
Judge rejects Purdue Pharma’s sweeping opioid settlement
A federal judge rejected OxyContin maker Purdue Pharma’s bankruptcy settlement of thousands of lawsuits over the opioid epidemic Thursday because of a provision that would protect members of the ...
katc
OxyContin maker Purdue proposes $10B plan to exit bankruptcy
The company that makes the prescription painkiller OxyContin would be transformed into a new entity that would funnel profits into combatting the U.S. opioid crisis under a $10 billion plan submitted ...
Business Wire
Purdue Pharma L.P. Plan of Reorganization Receives Overwhelming Creditor Support
STAMFORD, Conn.--(BUSINESS WIRE)--Purdue Pharma L.P. (“Purdue”) today announced that its Chapter 11 Plan of Reorganization (“Plan”) received support from more than 99% of voting creditors, based on ...